dc.contributor.author |
Талипова Нозима Шоолимовна |
|
dc.date.accessioned |
2023-05-27T05:33:53Z |
|
dc.date.available |
2023-05-27T05:33:53Z |
|
dc.date.issued |
2023-05-01 |
|
dc.identifier.uri |
http://repository.tma.uz/xmlui/handle/1/7997 |
|
dc.description.abstract |
Diabetes is one of the most common somatic diseases and it has social, economic and medical importance. Type II diabetes affects 6,28 % population of the world. Patients with diabetes have an increased risk of anxiety disorders [1]. There are many scientific works aimed at studying depression in diabetes . Anxiety can lead to the development of depression[2]. The above data show that early detection of alarming disorders is important in preventing the severe course and complications of the disease.Many specific studies show that anxiety leads to the development of metabolic syndrome and insulin resistance [5], which in turn can affect the development of diabetes type 2. |
en_US |
dc.language.iso |
en |
en_US |
dc.publisher |
Ташкент |
en_US |
dc.relation.ispartofseries |
УДК;616.89-008.454-02:616.379-008.64 |
|
dc.subject |
diabetes II type, anxiety, depression, anxyolitic therapy, HADS (Hospital Anxiety and Depression Scale) |
en_US |
dc.title |
THE PSYCHOLOGICAL ASPECTS OF DIABETES II |
en_US |
dc.type |
Article |
en_US |